Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 122.26 -3.47% -4.40
SRPT closed down 3.47 percent on Friday, March 22, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
12 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SRPT trend table...

Date Alert Name Type % Chg
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 200 DMA Resistance Bearish -3.47%
Mar 21 50 DMA Resistance Bearish -3.47%
Mar 21 Pocket Pivot Bullish Swing Setup -3.47%
Mar 21 Multiple of Ten Bearish Other -3.47%
Mar 21 Oversold Stochastic Weakness -3.47%
Mar 20 Stochastic Buy Signal Bullish -1.28%
Mar 20 Down 3 Days in a Row Weakness -1.28%
Mar 20 Down 4 Days in a Row Weakness -1.28%
Mar 20 Down 5 Days in a Row Weakness -1.28%

Older signals for SRPT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Biology Infectious Diseases Rare Diseases Duchenne Muscular Dystrophy Therapeutic Gene Modulation Antisense RNA
Is SRPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 21 Sell-siders say Biogen may seek acquisitions after aducanumab fail
Mar 15 Sarepta Therapeutics' Charts Look Risky
Mar 15 Jim Cramer Gives His Opinion On Bank Of America, Sarepta, Wendy's And More
Mar 14 Sarepta or Amarin: Who Is Controlling Expenses Better?
Mar 13 Sarepta and Amarin: What to Expect from Their EPS Growth
Mar 13 Sarepta or Amarin: Who’s Expected to Post Faster Revenue Growth?
Mar 13 What Analysts Recommend for Sarepta and Amarin in March
Mar 6 Why NIO, Brown-Forman, and Sarepta Therapeutics Slumped Today
Mar 6 Why Sarepta Therapeutics (SRPT) Stock Is Sinking Today
Mar 6 Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019
See more SRPT news...
Indicators
Indicator Value
52 Week High 176.5
52 Week Low 70.5
Average Volume 1,312,799
200-Day Moving Average 129.4293
50-Day Moving Average 131.6344
20-Day Moving Average 135.1185
10-Day Moving Average 128.484
Average True Range 5.9735
ADX 18.4
+DI 23.0611
-DI 26.7556
Chandelier Exit (Long, 3 ATRs ) 137.3095
Chandelier Exit (Short, 3 ATRs ) 139.5305
Upper Bollinger Band 152.4649
Lower Bollinger Band 117.7721
Percent B (%b) 0.13
BandWidth 25.675833
MACD Line -2.6917
MACD Signal Line -0.8115
MACD Histogram -1.8802
Fundamentals Value
Market Cap 7.85 Billion
Num Shares 64.2 Million
EPS -2.34
Price-to-Earnings (P/E) Ratio -52.25
Price-to-Sales 53.98
Price-to-Book 6.98
PEG Ratio 231.25
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 129.91
Resistance 3 (R3) 130.76 129.05 128.64
Resistance 2 (R2) 129.05 127.11 128.63 128.21
Resistance 1 (R1) 125.66 125.90 124.81 124.81 127.78
Pivot Point 123.95 123.95 123.53 123.53 123.95
Support 1 (S1) 120.56 122.01 119.71 119.71 116.74
Support 2 (S2) 118.85 120.80 118.43 116.31
Support 3 (S3) 115.46 118.85 115.89
Support 4 (S4) 114.61